Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video game therapy may improve spine mobility in children with cerebral palsy

NCT ID NCT07421505

Symptom relief Sponsor: Wroclaw University of Health and Sport Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adding exergaming (video games that require movement) to standard NDT-Bobath therapy can improve spinal mobility in children aged 10-15 with cerebral palsy. Forty-two participants will be split into two groups: one doing seated exergaming and the other standing exergaming, both alongside standard therapy. Researchers will measure changes in neck, back, and spine movement, as well as posture and body composition, right after the 3-month program and again 3 months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NDT-Bobath therapy and seated or standing exergaming
What this could lead to
If successful, this could show that adding exergaming to standard therapy improves spinal movement and posture in children with cerebral palsy.
What could go wrong
This is a small, early-stage study with only 42 participants, so results may not apply to all children with CP. It also does not test a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent from parents/guardians and the child (if capable) * GMFCS levels I-III (mild to moderate motor limitations) * Ability to maintain standing position * Ability to follow instructions and perform exercises * No prior exergaming therapy * No implanted electronic devices * No acute infections or inflammatory conditions * No metabolic disorders affecting bioimpedance measurements Exclusion Criteria: * GMFCS levels IV-V * Orthopedic surgery within the past 12 months * Seizure episodes within the past 6 months * Cognitive or behavioral impairments preventing cooperation * Severe spinal deformities (scoliosis \>40° or other significant changes) * Attendance at therapy sessions \<85%

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spastic diplegia cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy hemiplegia spastic diplegia spastic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spastic diplegia cerebral palsy Spastic hemiplegia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Specjalistyczne Centrum Medyczne im. Jana Pawła II S.A.

    Polanica-Zdrój, Lower Silesian Voivodeship, 57-320, Poland

  • Wroclaw University of Health and Sport Sciences

    Wroclaw, Lower Silesian Voivodeship, 51-612, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.